Quantbot Technologies’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.4K Buy
+4,280
New +$38.8K ﹤0.01% 1652
2024
Q2
Sell
-5,700
Closed -$78.4K 1790
2024
Q1
$78.4K Buy
+5,700
New +$67.7K ﹤0.01% 1254
2023
Q2
Sell
-2,480
Closed -$14.1K 1853
2023
Q1
$14.1K Buy
+2,480
New +$13K ﹤0.01% 1383
2022
Q2
Sell
-14,500
Closed -$77K 2009
2022
Q1
$77K Buy
+14,500
New +$131K 0.01% 1102
2021
Q4
Sell
-2,700
Closed -$56K 1798
2021
Q3
$56K Buy
+2,700
New +$54.7K ﹤0.01% 1091

Other funds holding ORIC

Quantbot Technologies's ORIC Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 4,280 shares worth $46.4K. The stake represents ﹤0.01% of the portfolio and ranks #1652 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in ORIC as recently as Q1 2024.

Quantbot Technologies first reported a position in ORIC in Q3 2021 and has held it in 5 quarters since. The position peaked at $78.4K in Q1 2024. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Quantbot Technologies held 4,280 shares of Oric Pharmaceuticals worth $46.4K as of Q2 2026.
  • Oric Pharmaceuticals was a new Quantbot Technologies position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1652 holding.
  • Quantbot Technologies first reported a position in Oric Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
  • Quantbot Technologies's Oric Pharmaceuticals position peaked at $78.4K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.